Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
ARUP Laboratories, |
RCV000755494 | SCV000603128 | uncertain significance | not provided | 2018-01-02 | criteria provided, single submitter | clinical testing | The c.2831C>T p.Pro944Leu variant (rs140368756), to our knowledge, is not reported in the medical literature or gene specific variation databases. This variant is listed in the genome Aggregation Database (gnomAD) with an overall population frequency of 0.3% (identified on 59 out of 23,816 chromosomes). The proline at position 944 is highly conserved, considering 12 species (Alamut v.2.10.0) and computational analyses of the effects of the p.Pro944Leu variant on protein structure and function provide conflicting results (SIFT: tolerated, MutationTaster: disease causing, PolyPhen-2: benign). Based on the available information, the clinical significance of the p.Pro944Leu variant cannot be predicted with certainty. |
Eurofins Ntd Llc |
RCV000508472 | SCV000709249 | likely benign | not specified | 2017-06-08 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000755494 | SCV001052949 | likely benign | not provided | 2024-01-22 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000755494 | SCV001802810 | likely benign | not provided | 2020-11-24 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003902808 | SCV004718430 | likely benign | COL2A1-related condition | 2019-08-28 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |